Summary

Europe Gene Expression Analysis Market is valued at approximately USD 1.09 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.0% over the forecast period 2024-2032. Gene expression analysis is the study of the activity of genes in a cell or tissue at a given moment. It involves measuring the levels of messenger RNA (mRNA) produced from each gene, as mRNA is the intermediate molecule between DNA and protein synthesis. This process provides insights into which genes are being actively transcribed and can give clues about the functional state of cells or tissues under different conditions. Also, with the increasing complexity of genomic data generated from gene expression analysis, there's a growing emphasis on bioinformatics tools and solutions for data integration, analysis, and interpretation. This trend is driving the demand for bioinformatics expertise and software platforms capable of handling large-scale gene expression datasets effectively which anticipated to create the demand for Gene Expression Analysis Market.

Moreover, Europe has a thriving biotechnology and pharmaceutical industry, which heavily relies on gene expression analysis for drug discovery, development, and clinical trials. The increasing investment in research and development by these industries fuels the demand for Gene Expression Analysis Market. Additionally, other factors that support the market growth are supportive government initiatives and funding, rising prevalence of chronic diseases, increasing adoption of personalized medicine, increasing investments in life sciences research, and continuous advancements in gene expression analysis technologies, such as Next-Generation Sequencing (NGS), microarray analysis, quantitative PCR (qPCR), and single-cell analysis techniques are driving market growth. However, high cost of the Instruments, and lack of skilled labor are expected to hinder the market growth during the forecast period 2024-2032.

The key countries considered for the Europe Gene Expression Analysis market study includes UK, Germany, France, Italy, Spain, and Rest of Europe. In 2023, Germany was the largest market. The Gene Expression Analysis market in Europe is driven by the strong biotechnology and pharmaceutical industry, growing focus on precision medicine, cohesive government support for research and innovation, growing adoption of next-generation sequencing, and increasing applications in clinical diagnostics. Also, Germany is at the forefront of biomarker discovery and drug development efforts. Gene expression analysis plays a critical role in identifying biomarkers for various diseases and in characterizing drug responses. The pharmaceutical industry's investment in translational research drives the demand for gene expression analysis platforms. For instance, in March 2024, Researchers from the German Centre for Diabetes Research (DZD), Helmholtz Munich, and Ludwig-Maximilians-University Munich (LMU) identified protein biomarkers associated with Coronary Heart Disease (CHD) in diabetic and non-diabetic individuals. Published in Cardiovascular Diabetology, the discovery offers insights into CHD development and potential diagnostic advancements.

Major market player included in this report are:
F. Hoffmann-La Roche
Oxford Gene Technology IP Limited
LGC Limited
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10

The detailed segments and sub-segment of the market are explained below:

By Technology
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Microarrays
Others

By Product Type
Instruments
Reagents and Consumables
Services

By End-user
Drug Discovery & Development
Diagnostic Laboratories
Academic Research Centers
By Region:
Europe
UK
Germany
France
Spain
Italy
ROE

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

ページTOPに戻る

Table of Contents

Chapter 1. Europe Gene Expression Analysis Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. Europe Gene Expression Analysis Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Technology
2.3.2. By Product Type
2.3.3. By End-User
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Europe Gene Expression Analysis Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Europe Gene Expression Analysis Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Europe Gene Expression Analysis Market Size & Forecasts by Technology 2022-2032
5.1. Polymerase Chain Reaction (PCR)
5.2. Next Generation Sequencing (NGS)
5.3. Microarrays
5.4. Others
Chapter 6. Europe Gene Expression Analysis Market Size & Forecasts by Product Type 2022-2032
6.1. Instruments
6.2. Reagents and Consumables
6.3. Services
Chapter 7. Europe Gene Expression Analysis Market Size & Forecasts by End-User 2022-2032
7.1. Drug Discovery & Development
7.2. Diagnostic Laboratories
7.3. Academic Research Centers
Chapter 8. Europe Gene Expression Analysis Market Size & Forecasts by Country 2022-2032
8.1. U.K. Gene Expression Analysis Market
8.1.1. Technology breakdown size & forecasts, 2022-2032
8.1.2. Product Type breakdown size & forecasts, 2022-2032
8.1.3. End-User breakdown size & forecasts, 2022-2032
8.2. Germany Gene Expression Analysis Market
8.3. France Gene Expression Analysis Market
8.4. Spain Gene Expression Analysis Market
8.5. Italy Gene Expression Analysis Market
8.6. Rest of Europe Gene Expression Analysis Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. F. Hoffmann-La Roche
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Oxford Gene Technology IP Limited
9.3.3. LGC Limited
9.3.4. Company 4
9.3.5. Company 5
9.3.6. Company 6
9.3.7. Company 7
9.3.8. Company 8
9.3.9. Company 9
9.3.10. Company 10
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes